Insider · CIK 0001710969

Reumuth Mary

Reports to the SEC for 1 company · ARLINGTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001710969

Forms 4 and 5

Insider transactions

48 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-10-23	KALAKALA BIO, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−967 sh	$0.82	−$792.94	28,906
2025-10-22	KALAKALA BIO, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−32.2K sh	$0.83	−$26.8K	29,873
2025-06-24	KALAKALA BIO, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−3,631 sh	$4.01	−$14.6K	62,100
2025-06-03	KALAKALA BIO, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−2,850 sh	$3.74	−$10.7K	65,731
2025-01-06	KALAKALA BIO, Inc.A Award	CHIEF FINANCIAL OFFICER	AAward	+10.1K sh	—	—	70,287
2025-01-06	KALAKALA BIO, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−1,706 sh	$7.63	−$13K	68,581
2025-01-06	KALAKALA BIO, Inc. · Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+45.2K sh	—	—	45,200
2024-06-26	KALAKALA BIO, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−4,163 sh	$4.75	−$19.8K	60,187
2024-05-31	KALAKALA BIO, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−1,786 sh	$6.09	−$10.9K	64,350
2024-01-04	KALAKALA BIO, Inc.A Award	CHIEF FINANCIAL OFFICER	AAward	+4,600 sh	—	—	67,363
2024-01-04	KALAKALA BIO, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−1,227 sh	$6.74	−$8,269.98	66,136
2024-01-04	KALAKALA BIO, Inc. · Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+20.5K sh	—	—	20,500
2023-06-22	KALAKALA BIO, Inc.A Award	CHIEF FINANCIAL OFFICER	AAward	+36.1K sh	—	—	62,763
2023-06-22	KALAKALA BIO, Inc. · Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+48.2K sh	—	—	48,192
2023-05-31	KALAKALA BIO, Inc.A Award	CHIEF FINANCIAL OFFICER	AAward	+14.7K sh	—	—	26,619
2023-05-31	KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer	CHIEF FINANCIAL OFFICER	DDisposition to Issuer	−1,841 sh	—	—	0
2023-05-31	KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer	CHIEF FINANCIAL OFFICER	DDisposition to Issuer	−578 sh	—	—	0
2023-05-31	KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer	CHIEF FINANCIAL OFFICER	DDisposition to Issuer	−1,399 sh	—	—	0
2023-05-31	KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer	CHIEF FINANCIAL OFFICER	DDisposition to Issuer	−2,999 sh	—	—	0
2023-05-31	KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer	CHIEF FINANCIAL OFFICER	DDisposition to Issuer	−2,399 sh	—	—	0
2023-05-31	KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer	CHIEF FINANCIAL OFFICER	DDisposition to Issuer	−1,813 sh	—	—	0
2023-05-31	KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer	CHIEF FINANCIAL OFFICER	DDisposition to Issuer	−3,059 sh	—	—	0
2023-05-31	KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer	CHIEF FINANCIAL OFFICER	DDisposition to Issuer	−648 sh	—	—	0
2023-03-14	KALAKALA BIO, Inc. · Stock Option (Right to Buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+432 sh	—	—	432
2023-01-04	KALAKALA BIO, Inc.A Award	CHIEF FINANCIAL OFFICER	AAward	+9,525 sh	—	—	11,943
2023-01-04	KALAKALA BIO, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−60 sh	$28.54	−$1,712.4	11,883
2022-10-26	KALAKALA BIO, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−194 sh	$6.51	−$1,262.94	2,418
2022-06-27	KALAKALA BIO, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−2,613 sh	$0.37	−$966.81	130,595
2022-01-04	KALAKALA BIO, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−2,850 sh	$1.30	−$3,705	133,208
2022-01-03	KALAKALA BIO, Inc. · Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+153K sh	—	—	153,000
2021-10-26	KALAKALA BIO, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−9,449 sh	$1.80	−$17K	136,058
2021-06-28	KALAKALA BIO, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−2,452 sh	$5.77	−$14.1K	145,507
2021-01-04	KALAKALA BIO, Inc.A Award	CHIEF FINANCIAL OFFICER	AAward	+22.7K sh	—	—	147,959
2021-01-04	KALAKALA BIO, Inc. · Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+90.7K sh	—	—	90,667
2020-10-26	KALAKALA BIO, Inc.A Award	CHIEF FINANCIAL OFFICER	AAward	+61K sh	—	—	125,293
2020-06-25	KALAKALA BIO, Inc.A Award	CHIEF FINANCIAL OFFICER	AAward	+16K sh	—	—	64,293
2020-06-09	KALAKALA BIO, Inc.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+11.5K sh	$2.30	+$26.5K	16,336
2020-06-09	KALAKALA BIO, Inc.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+5,077 sh	$5.21	+$26.5K	21,413
2020-06-09	KALAKALA BIO, Inc.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+15.4K sh	$2.30	+$35.3K	36,773
2020-06-09	KALAKALA BIO, Inc.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+11.5K sh	$2.30	+$26.5K	48,293
2020-06-09	KALAKALA BIO, Inc. · Stock Option (right to buy)M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−11.5K sh	—	—	0
2020-06-09	KALAKALA BIO, Inc. · Stock Option (right to buy)M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−5,077 sh	—	—	0
2020-06-09	KALAKALA BIO, Inc. · Stock Option (right to buy)M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−15.4K sh	—	—	0
2020-06-09	KALAKALA BIO, Inc. · Stock Option (right to buy)M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−11.5K sh	—	—	0
2020-01-02	KALAKALA BIO, Inc. · Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+120K sh	—	—	120,000
2019-01-02	KALAKALA BIO, Inc. · Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+150K sh	—	—	150,000
2018-02-07	KALAKALA BIO, Inc. · Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+70K sh	—	—	70,000
2017-07-19	KALAKALA BIO, Inc. · Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+29K sh	—	—	28,973

Recent filings

Accepted (ET)
Oct 244
Reumuth Mary0001710969-25-000003
SEC(opens sec.gov)
Jun 264
Reumuth Mary0001415889-25-018320
SEC(opens sec.gov)
Jun 44
Reumuth Mary0001415889-25-015680
SEC(opens sec.gov)
Jan 74
Reumuth Mary0001415889-25-001059
SEC(opens sec.gov)
Jun 274
Reumuth Mary0001415889-24-018375
SEC(opens sec.gov)
Jun 34
Reumuth Mary0001415889-24-015224
SEC(opens sec.gov)
Jan 54
Reumuth Mary0001415889-24-000767
SEC(opens sec.gov)
Jun 234
Reumuth Mary0001415889-23-010285
SEC(opens sec.gov)
Jun 24
Reumuth Mary0001415889-23-009136
SEC(opens sec.gov)

Companies

KALA BIO, Inc.CHIEF FINANCIAL OFFICERKALA

Address

C/O KALA BIO, INC. 1167 MASSACHUSETTS AVENUE

ARLINGTON, MA, 02476